Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples
No Thumbnail Available
Date
2025-01-09
Journal Title
Journal ISSN
Volume Title
Publisher
Emerging Infectious Diseases
Abstract
Carbapenems have been used for many years to treat severe nosocomial Enterobacteriaceae infections. The spread
of resistance to these drugs among other bacterial families
is an emerging problem worldwide, mostly caused by New
Delhi metallo-β-lactamase (NDM-1). We screened for the
prevalence of NDM-1–expressing enteric pathogens from
hospitalized patients with acute diarrhea in Kolkata, India,
and identified 27 Vibrio fluvialis–harboring blaNDM-1 (NDMVF) strains. These isolates were also resistant to all the
tested antimicrobial drugs except doxycycline. The large
plasmid of V. fluvialis harboring blaNDM-1 could be easily
transferred to other enteric pathogens. Genes flanking the
blaNDM-1 were found to be identical to the reported sequence
from an Escherichia coli isolate. Analyses showed that the
V. fluvialis possessing the NDM-VF region belonged to different clones. The pathogenicity of V. fluvialis to humans
and its ubiquitous presence in the environment call for constant monitoring of this species for emerging antimicrobial
drug resistance.
Description
Carbapenems have been used for many years to treat severe nosocomial Enterobacteriaceae infections. The spread
of resistance to these drugs among other bacterial families
is an emerging problem worldwide, mostly caused by New
Delhi metallo-β-lactamase (NDM-1). We screened for the
prevalence of NDM-1–expressing enteric pathogens from
hospitalized patients with acute diarrhea in Kolkata, India,
and identified 27 Vibrio fluvialis–harboring blaNDM-1 (NDMVF) strains. These isolates were also resistant to all the
tested antimicrobial drugs except doxycycline. The large
plasmid of V. fluvialis harboring blaNDM-1 could be easily
transferred to other enteric pathogens. Genes flanking the
blaNDM-1 were found to be identical to the reported sequence
from an Escherichia coli isolate. Analyses showed that the
V. fluvialis possessing the NDM-VF region belonged to different clones. The pathogenicity of V. fluvialis to humans
and its ubiquitous presence in the environment call for constant monitoring of this species for emerging antimicrobial
drug resistance.